Biotechnology News and Research

RSS

CDC interventions targeting gestational diabetes may help mitigate risks for mother and baby

Diabetes in pregnant women can have serious health consequences for both mother and baby, and the U.S. Centers for Disease Control and Prevention has identified four target areas in which increased surveillance, screening, and preventive care can improve maternal and infant health.

29 May 2018

Bioethicist: 'Right to Try Act' will not benefit terminally-ill patients

Gregory Pence, Ph.D., professor and Chair of Philosophy, teaches bioethics at the University of Alabama at Birmingham.

26 May 2018

Scientists develop new method to speed up genome evolution of baker's yeast

Scientists have created a new way of speeding up the genome evolution of baker's yeast Saccharomyces cerevisiae, the same yeast people use for bread and beer production, to develop a synthetic yeast strain that can be transformed on demand for use in various industrial applications.

26 May 2018

Lung-on-a-chip technology could streamline drug-testing for pulmonary fibrosis

Developing new medicines to treat pulmonary fibrosis, one of the most common and serious forms of lung disease, is not easy.

25 May 2018

Origami inspires researchers to develop new solution for tissue regeneration

Origami - the Japanese art of folding paper into shapes and figures - dates back to the sixth century. At UMass Lowell, it is inspiring researchers as they develop a 21st-century solution to the shortage of tissue and organ donors.

25 May 2018

Study links cell size with commitment to division

How does a cell know when to divide? We know that hundreds of genes contribute to a wave of activity linked to cell division, but to generate that wave new research shows that cells must first grow large enough to produce four key proteins in adequate amounts.

24 May 2018

Advanced genetics study of TB bacteria uncovers virulent 'Beijing lineage' strain among young adults

LSTM's Dr Maxine Caws is co-lead investigator on an advanced genetics study published in Nature Genetics(link is external), which has shown that a virulent strain of tuberculosis (TB) has adapted to transmit among young adults in Ho Chi Minh City, Vietnam.

23 May 2018

ToolGen's CRISPR/Cas9 gene editing platform improves T-cell anti-tumor activity in mouse model

ToolGen, Inc., a biotechnology company specializing in genome editing, today announced data demonstrating that blocking a molecular pathway that down-regulates T-cell activity with the Company’s CRISPR/Cas9 gene editing platform results in increased T-cell receptor signaling, in vitro, and in improved anti-tumor activity when tested against in a mouse glioblastoma tumor model.

22 May 2018

CRISPR-Cas9-based strategy allows researchers to precisely alter hundreds of different genes

Geneticists have been using model organisms ranging from the house mouse to the single-cell bakers' yeast, Saccharomyces cerevisiae, to study basic biological processes that regulate human development and physiology, and that can be compromised in various diseases.

22 May 2018

Higher body temperatures speed the bodies' responses to infections and tumors, finds research

The hotter our body temperature, the more our bodies speed up a key defense system that fights against tumors, wounds or infections, new research by a multidisciplinary team of mathematicians and biologists from the Universities of Warwick and Manchester has found.

21 May 2018

Clinical trial begins enrollment to test safety of experimental MERS treatments

Enrollment has begun in an early-stage clinical trial testing the safety of two human monoclonal antibodies (mAbs) designed to treat people infected with Middle East respiratory syndrome coronavirus (MERS-CoV).

18 May 2018

Rocket Pharma partners with Stanford University to advance FA and PKD gene therapy research

Rocket Pharmaceuticals, Inc., a leading U.S.-based multi-platform gene therapy company, and the Stanford University School of Medicine today announced a strategic collaboration to support the advancement of Fanconi Anemia and Pyruvate Kinase Deficiency gene therapy research.

17 May 2018

Obsidian Therapeutics presents preclinical data on regulated IL12 and IL15 programs

Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced that the company presented preclinical data on its regulated IL12 and IL15 programs at the Annual Meeting of the American Society of Gene and Cell Therapy in Chicago, IL.

17 May 2018

Tufts University, BioLabs announce the opening of new biotech facility for life sciences entrepreneurs

Tufts University and BioLabs today announced the opening of Tufts Launchpad | BioLabs, a full-service biotech facility supporting high-potential, early-stage life sciences startup ventures in the Boston area.

16 May 2018

Research Ready program launched for physician practices interested in becoming a study site

Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients, has launched a Research Ready program for physician practices interested in becoming a study site.

15 May 2018

ICON and DuPage Medical Group announce clinical research partnership

ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.

14 May 2018

Havard University grants license to Beam Therapeutics to develop new base editing technology

Harvard University has granted a worldwide license to Beam Therapeutics, Inc., to develop and commercialize a suite of revolutionary DNA base editing technologies for the treatment of human disease.

14 May 2018

Researchers urge re-examination of colonial models in regulation of traditional medicine practitioners

Two commentaries in JACM, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers that is dedicated to examining paradigm, practice, and policy advancing integrative health, raise questions about whether the value to health care of traditional, complementary, and integrative practices and practitioners is unfairly de-valued by the dominant biomedical model.

14 May 2018

New study aims to mitigate risks associated with treatment of multiple myeloma

In a 10-patient cohort study led by Dr. Jean Roy that aims to understand how to mitigate the risks associated with the treatment of multiple myeloma, a malignant cancer, researchers have adopted an innovative approach based on the unique immunological properties of umbilical cord blood in an effort to improve the safety and efficiency of allografting, the preferred treatment for this disease

11 May 2018

£4 million project seeks to find new therapies for promoting tissue repair

Stem cell scientists are to join forces with doctors to investigate methods of promoting tissue repair in the liver, lungs and joints.

9 May 2018

Biotechnology News and Research

CDC interventions targeting gestational diabetes may help mitigate risks for mother and baby

Bioethicist: 'Right to Try Act' will not benefit terminally-ill patients

Scientists develop new method to speed up genome evolution of baker's yeast

Lung-on-a-chip technology could streamline drug-testing for pulmonary fibrosis

Origami inspires researchers to develop new solution for tissue regeneration

Study links cell size with commitment to division

Advanced genetics study of TB bacteria uncovers virulent 'Beijing lineage' strain among young adults

ToolGen's CRISPR/Cas9 gene editing platform improves T-cell anti-tumor activity in mouse model

CRISPR-Cas9-based strategy allows researchers to precisely alter hundreds of different genes

Higher body temperatures speed the bodies' responses to infections and tumors, finds research

Clinical trial begins enrollment to test safety of experimental MERS treatments

Rocket Pharma partners with Stanford University to advance FA and PKD gene therapy research

Obsidian Therapeutics presents preclinical data on regulated IL12 and IL15 programs

Tufts University, BioLabs announce the opening of new biotech facility for life sciences entrepreneurs

Research Ready program launched for physician practices interested in becoming a study site

ICON and DuPage Medical Group announce clinical research partnership

Havard University grants license to Beam Therapeutics to develop new base editing technology

Researchers urge re-examination of colonial models in regulation of traditional medicine practitioners

New study aims to mitigate risks associated with treatment of multiple myeloma

£4 million project seeks to find new therapies for promoting tissue repair

Event guide: 3rd IMPACCT Real World Evidence Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News